You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

SODIUM THIOSULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Thiosulfate, and what generic alternatives are available?

Sodium Thiosulfate is a drug marketed by Us Army and Hope Pharms and is included in two NDAs. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-eight patent family members in eleven countries.

The generic ingredient in SODIUM THIOSULFATE is sodium thiosulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium thiosulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Thiosulfate

A generic version of SODIUM THIOSULFATE was approved as sodium thiosulfate by HOPE PHARMS on February 14th, 2012.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SODIUM THIOSULFATE?
  • What are the global sales for SODIUM THIOSULFATE?
  • What is Average Wholesale Price for SODIUM THIOSULFATE?
Summary for SODIUM THIOSULFATE
Drug patent expirations by year for SODIUM THIOSULFATE
Recent Clinical Trials for SODIUM THIOSULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Pontificia Universidad Catolica de ChilePhase 1/Phase 2
Liga Panamericana de Asociaciones de Reumatologia (PANLAR)Phase 1/Phase 2
The First Affiliated Hospital of ShiheziI UniversityN/A

See all SODIUM THIOSULFATE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for SODIUM THIOSULFATE
Paragraph IV (Patent) Challenges for SODIUM THIOSULFATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PEDMARK Intravenous Injection sodium thiosulfate 12.5 g/100 mL 212937 1 2022-10-18
PEDMARK Intravenous Injection sodium thiosulfate 12.5 g/100 mL 212937 1 2022-10-07
SODIUM THIOSULFATE Intravenous Injection sodium thiosulfate 12.5 g/50 mL 203923 1 2022-04-29

US Patents and Regulatory Information for SODIUM THIOSULFATE

SODIUM THIOSULFATE is protected by five US patents.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army SODIUM THIOSULFATE sodium thiosulfate INJECTABLE;INJECTION 020166-001 Feb 14, 1992 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes 10,479,686 ⤷  Subscribe Y ⤷  Subscribe
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes 9,345,724 ⤷  Subscribe Y Y ⤷  Subscribe
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes 8,496,973 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

EU/EMA Drug Approvals for SODIUM THIOSULFATE

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Fennec Pharmaceuticals (EU) Limited Pedmarqsi sodium thiosulfate EMEA/H/C/005130
Pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
Authorised no no no 2023-05-26
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for SODIUM THIOSULFATE

See the table below for patents covering SODIUM THIOSULFATE around the world.

Country Patent Number Title Estimated Expiration
Japan 2012532824 ⤷  Subscribe
Portugal 2451435 ⤷  Subscribe
Japan 2019048852 チオ硫酸ナトリウムを含有する薬学的組成物 (SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS) ⤷  Subscribe
Hungary E035519 ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for SODIUM THIOSULFATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0290047 SPC/GB97/078 United Kingdom ⤷  Subscribe PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
1666481 17C1031 France ⤷  Subscribe PRODUCT NAME: TOFACITINIB,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,DONT LE CITRATE DE SODIUM; REGISTRATION NO/DATE: EU/1/17/1178 20170324
2340828 LUC00195 Luxembourg ⤷  Subscribe PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE DE SEL DE SODIUM SACUBITRIL VALSARTAN, C'EST-A-DIRE (((S)-N-VALERYL-N-((2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL)-METHYL)-VALINE) ((2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-ESTER ETHYLIQUE D'ACIDE PENTANOIQUE))NA3 X H2O, DANS LEQUEL X EST 0 A 3; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123
2673237 1990016-6 Sweden ⤷  Subscribe PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; REG. NO/DATE: EU/1/17/1173 20180326
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

SODIUM THIOSULFATE Market Analysis and Financial Projection Experimental

Sodium Thiosulfate Market Dynamics and Financial Trajectory

Introduction to Sodium Thiosulfate

Sodium thiosulfate is a versatile chemical compound with a wide range of applications, including medical, photographic processing, iodometry, gold extraction, and water treatment. Understanding its market dynamics and financial trajectory is crucial for investors, manufacturers, and end-users.

Market Size and Growth

The sodium thiosulfate market is projected to experience significant growth over the next few years. As of 2024, the market size is estimated to be USD 114.33 million and is expected to reach USD 149.79 million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 5.55% during the forecast period[1][5].

Regional Market Analysis

Asia-Pacific Dominance

The Asia-Pacific region is the largest and fastest-growing market for sodium thiosulfate. This dominance is driven by high demand from the water treatment sector in countries such as China, India, Japan, and ASEAN. China, being the largest producer of gold globally, also contributes significantly to the demand for sodium thiosulfate in gold extraction[1][4].

North American Market

North America is anticipated to be one of the fastest-developing regions during the forecast period, primarily due to the growing demand for medical applications and pharmaceutical products. The U.S., with its substantial pharmaceutical industry, is a key driver of this growth[4].

Market Drivers

Growing Demand for Water Treatment

The increasing adoption of water treatment systems to avoid the spread of aquatic diseases is a significant driver for the sodium thiosulfate market. Sodium thiosulfate is used to decrease chlorine levels and treat settled backwash water in spas, swimming pools, and aquaria, making it an essential component in water treatment processes[4].

Medical Applications

The medical sector is another key driver, with sodium thiosulfate being used in various medical applications, including the treatment of cyanide poisoning and as a component in drugs like PEDMARK, which is used to prevent hearing loss in pediatric cancer patients. The approval of PEDMARK by the FDA in 2022 has further boosted the market[1][4].

Gold Extraction

Sodium thiosulfate's use in gold leaching processes is another significant driver. China's large gold production, accounting for around 9.3% of global production in 2021, contributes to the high demand for sodium thiosulfate in this sector[1].

Market Restraints

Side Effects and Health Concerns

Concerns about the side effects of intravenous administration of sodium thiosulfate are expected to hinder market growth. These side effects can be a deterrent for some medical applications, potentially limiting the market's expansion[1].

Volatility in Raw Material Prices

Volatility in the prices of raw materials used for the production of sodium thiosulfate can act as a market restraint. Fluctuations in raw material costs can impact the profitability and stability of sodium thiosulfate manufacturers[4].

Financial Trajectory

Capital Investments and Operating Expenses

Setting up a sodium thiosulfate manufacturing plant requires significant capital investments. The project economics include detailed analyses of capital expenditure (CapEx), operating expenditure (OpEx), income projections, taxation, depreciation, and liquidity analysis. Manufacturers need to consider fixed and variable costs, direct and indirect costs, and expected Return on Investment (ROI) and Net Present Value (NPV)[2].

Revenue Projections

The market is expected to generate substantial revenue, with the global sodium thiosulfate market valued at USD 96.36 million in 2021 and projected to reach USD 159.48 million by 2029, registering a CAGR of 6.50% during the forecast period[4].

Funding and Investment

Companies like Fennec Pharmaceuticals Inc. have secured significant investments, such as the USD 5 million senior secured promissory notes from Petrichor Healthcare Capital Management, which highlights the potential for financial growth and investment opportunities in the sodium thiosulfate market[1].

Regulatory and Approval Processes

The setup of a sodium thiosulfate manufacturing plant involves navigating through various regulatory procedures and obtaining necessary approvals. Manufacturers must comply with certifications and regulations to ensure the quality and safety of the product[2].

Key Players

The sodium thiosulfate market is dominated by several key players, including INEOS, Liyang Qingfeng Fine chemical Co. Ltd, Changsha Weichuang Chemical Co. Ltd., Haimen Wuyang Chemical Industry Co. Ltd., and Nissei Corporation. These companies play a crucial role in driving market growth through their production capacities and distribution networks[1].

Emerging Opportunities

Medical Industry

The emerging use of sodium thiosulfate in the medical industry is likely to create significant opportunities for market growth. New approvals and applications in the medical sector can expand the market's scope and demand[1].

Retail Expansion

Retailers hold prominent expansion avenues during the forecast period, particularly in regions with growing medical and healthcare sectors. This expansion can further increase business opportunities for sodium thiosulfate manufacturers and distributors[4].

Conclusion

The sodium thiosulfate market is poised for steady growth driven by its diverse applications, particularly in water treatment, medical, and gold extraction sectors. While it faces challenges such as side effects and raw material price volatility, the market's financial trajectory indicates promising revenue projections and investment opportunities.

Key Takeaways

  • The sodium thiosulfate market is expected to grow from USD 114.33 million in 2024 to USD 149.79 million by 2029 at a CAGR of 5.55%.
  • The Asia-Pacific region dominates the market due to high demand from water treatment and gold extraction.
  • Medical applications, including the use in PEDMARK, are significant drivers.
  • Volatility in raw material prices and side effects of intravenous administration are market restraints.
  • Key players include INEOS, Liyang Qingfeng Fine chemical Co. Ltd, and others.
  • Emerging opportunities lie in the medical industry and retail expansion.

FAQs

Q: What is the current market size of the sodium thiosulfate market?

The sodium thiosulfate market size is estimated to be USD 114.33 million in 2024[1].

Q: What is the expected CAGR of the sodium thiosulfate market from 2024 to 2029?

The sodium thiosulfate market is expected to grow at a CAGR of 5.55% from 2024 to 2029[1].

Q: Which region dominates the sodium thiosulfate market?

The Asia-Pacific region dominates the sodium thiosulfate market due to high demand from water treatment and gold extraction sectors[1][4].

Q: What are the major applications of sodium thiosulfate?

Major applications include water treatment, medical, photographic processing, iodometry, and gold extraction[1][4].

Q: Who are the key players in the sodium thiosulfate market?

Key players include INEOS, Liyang Qingfeng Fine chemical Co. Ltd, Changsha Weichuang Chemical Co. Ltd., Haimen Wuyang Chemical Industry Co. Ltd., and Nissei Corporation[1].

Sources

  1. Mordor Intelligence, Sodium Thiosulphate Market - Size, Share & Analysis, https://www.mordorintelligence.com/industry-reports/sodium-thiosulphate-market
  2. IMARC Group, Sodium Thiosulfate Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue, https://www.imarcgroup.com/sodium-thiosulfate-manufacturing-plant-project-report
  3. Grand View Research, Sodium Thiosulphate Market Size, Share | Global Industry Report ..., https://www.grandviewresearch.com/industry-analysis/sodium-thiosulphate-market
  4. Data Bridge Market Research, Sodium Thiosulphate Market Analysis & Growth, https://www.databridgemarketresearch.com/reports/global-sodium-thiosulphate-market
  5. Mordor Intelligence, Sodium Thiosulphate Market Size | Mordor Intelligence, https://www.mordorintelligence.com/industry-reports/sodium-thiosulphate-market/market-size

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.